DE602007004642D1 - Pharmazeutische zusammensetzung mit einem dihydrobenzofuranyl-isoindolin und einer lipophilen komponente - Google Patents
Pharmazeutische zusammensetzung mit einem dihydrobenzofuranyl-isoindolin und einer lipophilen komponenteInfo
- Publication number
- DE602007004642D1 DE602007004642D1 DE602007004642T DE602007004642T DE602007004642D1 DE 602007004642 D1 DE602007004642 D1 DE 602007004642D1 DE 602007004642 T DE602007004642 T DE 602007004642T DE 602007004642 T DE602007004642 T DE 602007004642T DE 602007004642 D1 DE602007004642 D1 DE 602007004642D1
- Authority
- DE
- Germany
- Prior art keywords
- dihydrobenzofuranyl
- isoindoline
- pharmaceutical composition
- lipophilic component
- lipophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006303800 | 2006-11-09 | ||
PCT/JP2007/072141 WO2008056822A1 (en) | 2006-11-09 | 2007-11-08 | Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602007004642D1 true DE602007004642D1 (de) | 2010-03-18 |
Family
ID=38942774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602007004642T Active DE602007004642D1 (de) | 2006-11-09 | 2007-11-08 | Pharmazeutische zusammensetzung mit einem dihydrobenzofuranyl-isoindolin und einer lipophilen komponente |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100273852A1 (de) |
EP (1) | EP2079455B1 (de) |
JP (1) | JP2010509188A (de) |
AR (1) | AR063618A1 (de) |
AT (1) | ATE456365T1 (de) |
CA (1) | CA2668864A1 (de) |
CL (1) | CL2007003217A1 (de) |
DE (1) | DE602007004642D1 (de) |
PE (1) | PE20081491A1 (de) |
TW (1) | TW200833374A (de) |
WO (1) | WO2008056822A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6982870B2 (ja) * | 2015-05-06 | 2021-12-17 | シンアジャル コーポレイション | 薬物粒子を含有する医薬懸濁液、それらの投与のためのデバイス、およびそれらの使用方法 |
JP7492917B2 (ja) | 2018-02-09 | 2024-05-30 | デシベル セラピューティクス インコーポレイテッド | 抗白金化学保護剤を含む高張医薬組成物 |
US10813947B1 (en) | 2019-05-31 | 2020-10-27 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
ATE261435T1 (de) * | 1998-12-04 | 2004-03-15 | Takeda Chemical Industries Ltd | Benzofuranderivate, verfahren zu ihrer herstellung und deren verwendungen |
CN1431896A (zh) * | 2000-04-04 | 2003-07-23 | 盐野义制药株式会社 | 含有高脂溶性药物的油性组合物 |
CA2432410A1 (en) * | 2000-12-28 | 2002-07-11 | Takeda Chemical Industries, Ltd. | Process for preparing optically active 2,3-dihydro- benzofuran compounds |
WO2003051355A1 (fr) * | 2001-12-19 | 2003-06-26 | Takeda Chemical Industries, Ltd. | Compositions solides refermant des composes instables a l'oxygene et procede de stabilisation de ces composes |
KR101011657B1 (ko) * | 2002-03-01 | 2011-01-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 항우울제 |
-
2007
- 2007-11-08 TW TW096142176A patent/TW200833374A/zh unknown
- 2007-11-08 CL CL200703217A patent/CL2007003217A1/es unknown
- 2007-11-08 CA CA002668864A patent/CA2668864A1/en not_active Abandoned
- 2007-11-08 DE DE602007004642T patent/DE602007004642D1/de active Active
- 2007-11-08 US US12/513,847 patent/US20100273852A1/en not_active Abandoned
- 2007-11-08 AT AT07831871T patent/ATE456365T1/de not_active IP Right Cessation
- 2007-11-08 WO PCT/JP2007/072141 patent/WO2008056822A1/en active Application Filing
- 2007-11-08 EP EP07831871A patent/EP2079455B1/de not_active Not-in-force
- 2007-11-08 PE PE2007001543A patent/PE20081491A1/es not_active Application Discontinuation
- 2007-11-08 JP JP2009517780A patent/JP2010509188A/ja not_active Withdrawn
- 2007-11-08 AR ARP070104976A patent/AR063618A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2079455B1 (de) | 2010-01-27 |
US20100273852A1 (en) | 2010-10-28 |
ATE456365T1 (de) | 2010-02-15 |
CL2007003217A1 (es) | 2008-07-04 |
JP2010509188A (ja) | 2010-03-25 |
WO2008056822A1 (en) | 2008-05-15 |
CA2668864A1 (en) | 2008-05-15 |
TW200833374A (en) | 2008-08-16 |
EP2079455A1 (de) | 2009-07-22 |
PE20081491A1 (es) | 2008-11-12 |
AR063618A1 (es) | 2009-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006016270D1 (de) | Pharmazeutische zusammensetzungen mit imatinib und einem freisetzungsverzögerer | |
ATE542815T1 (de) | Kokristalle und pharmazeutische zusammensetzungen damit | |
CR10725A (es) | Compuestos de pirazolina y su uso y composiones farmaceuticas | |
DE602005012107D1 (de) | Pharmazeutische formulierungen mit einem antibioti | |
GB0413730D0 (en) | A pharmaceutical composition and its use | |
IL179795A0 (en) | A pharmaceutical composition and its use | |
DK2399580T3 (da) | Farmaceutiske doseringsformer | |
IL212915A0 (en) | Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor | |
ATE493119T1 (de) | Pharmazeutische zusammensetzung | |
ATE530546T1 (de) | Kokristalle und pharmazeutische zusammensetzungen damit | |
HUS1800034I1 (hu) | Anti-FGF23 ellenanyag és anti-FGF23 ellenanyagot tartalmazó gyógyászati készítmény | |
ATE489944T1 (de) | Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür | |
ATE499368T1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
BRPI0716754A2 (pt) | composiÇço À base de xantoxilina e a respectiva utilizaÇço em cosmÉtica | |
ATE499089T1 (de) | Pharmazeutische zusammensetzung in form von beschichteten mikrokügelchen zur modifizierten freisetzung eines muskelrelaxans und eines nsar | |
ZA200803152B (en) | Oramucosal pharmaceutical dosage form | |
HK1130049A1 (en) | Tricyclic compound and pharmaceutical use thereof | |
EP2098513A4 (de) | Tricyclische verbindung und ihre pharmazeutische verwendung | |
GB0614365D0 (en) | Pharmaceutical compositions and their use | |
DE602007004642D1 (de) | Pharmazeutische zusammensetzung mit einem dihydrobenzofuranyl-isoindolin und einer lipophilen komponente | |
ATE540672T1 (de) | Pharmazeutische zusammensetzung und verfahren | |
FR2907786B1 (fr) | Thionucleosides et applications pharmaceutiques | |
MX2008003644A (en) | Particulate lipid pharmaceutical composition | |
BRPI0810057A2 (pt) | Composição farmacêutica contendo floroglucinol e paracetamol | |
IL189827A0 (en) | Pharmaceutical dosage forms and compositions comprising lecoztan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |